Point72 Hong Kong LTD Black Diamond Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.5 - $3.63 $214 - $519	-143 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.66 - $5.61 $2,761 - $5,823	-1,038 Reduced 87.89%	143 $0
Q4 2021 Feb 14, 2022	BUY	$5.18 - $8.48 $6,117 - $10,014	1,181 New	1,181 $6,000
Q2 2021 Aug 16, 2021	SELL	$12.19 - $28.17 $3,010 - $6,957	-247 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$22.23 - $34.75 $5,490 - $8,583	247 New	247 $6,000

47.6M

2.9K

69.4K

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $68.3M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.